AOU | Jotup

Press Release: Sarclisa® (isatuximab) plus KRd significantly improved rate of minimal residual disease negativity in transplant-eligible patients with newly diagnosed multiple myeloma versus KRd alone

Retrieved on:

Lunedì, Dicembre 11, 2023

The Phase 3 trial investigating Sarclisa® (isatuximab) in combination with carfilzomib, lenalidomide and dexamethasone (KRd) showed a statistically significant improvement in the rate of minimal residual disease (MRD) negativity, compared with KRd alone, after autologous stem cell transplant (ASCT) consolidation in transplant-eligible patients with newly diagnosed multiple myeloma (MM).

Key Points:

The Phase 3 trial investigating Sarclisa® (isatuximab) in combination with carfilzomib, lenalidomide and dexamethasone (KRd) showed a statistically significant improvement in the rate of minimal residual disease (MRD) negativity, compared with KRd alone, after autologous stem cell transplant (ASCT) consolidation in transplant-eligible patients with newly diagnosed multiple myeloma (MM).
The respective rates of MRD negativity at sensitivity of 10-6 were 67% versus 48% (OR 1.93; p=0.006).
There was a statistically significant difference in MRD negativity rates after induction with Sarclisa in combination with KRd versus KRd (10-5: 45% versus 26%, p
Effective front-line treatment is critical for newly diagnosed patients, because achieving undetectable levels of disease early in the treatment journey may lead to better long-term outcomes.

AOU Parma chooses Deenova's RFID solution for medical device traceability and its proven benefits

Retrieved on:

Giovedì, Luglio 20, 2023

Sentinel, D8, AOU, RFID, Rotation, The, Hospital, Patient safety, Sentry, Health, Medical device

Deenova 's D8 Series , which will be implemented at AOU Parma, offers widely recognized benefits through a combination of specialized personnel, exclusive software and hardware, and personalized service design.

Key Points:

Deenova 's D8 Series , which will be implemented at AOU Parma, offers widely recognized benefits through a combination of specialized personnel, exclusive software and hardware, and personalized service design.
The D8 suite of products, including Orbit Software, Sentinel RFID Cabinet, Sentry RFID Bin, and Check-in (RFID Kanban System), identifies and tracks everything handled by the hospital pharmacy and directed to operating theatres.
Giorgio Pavesi , CEO of Deenova declared "We are delighted to continue expanding our customer base in Italy, by adding AOU Parma.
Our mission is to deliver the most cost-effective, digital, and automated solutions for medication and medical device management.

AOU Parma chooses Deenova's RFID solution for medical device traceability and its proven benefits

Retrieved on:

Giovedì, Luglio 20, 2023

Sentinel, D8, AOU, RFID, Rotation, The, Hospital, Patient safety, Sentry, Health, Medical device

Deenova 's D8 Series , which will be implemented at AOU Parma, offers widely recognized benefits through a combination of specialized personnel, exclusive software and hardware, and personalized service design.

Key Points:

Deenova 's D8 Series , which will be implemented at AOU Parma, offers widely recognized benefits through a combination of specialized personnel, exclusive software and hardware, and personalized service design.
The D8 suite of products, including Orbit Software, Sentinel RFID Cabinet, Sentry RFID Bin, and Check-in (RFID Kanban System), identifies and tracks everything handled by the hospital pharmacy and directed to operating theatres.
Giorgio Pavesi , CEO of Deenova declared "We are delighted to continue expanding our customer base in Italy, by adding AOU Parma.
Our mission is to deliver the most cost-effective, digital, and automated solutions for medication and medical device management.

EQS-News: Medacta Launches 360° (Anterior and Posterior) Cervical Platform, Highlighting MySpine Cervical, a Further Enhancement to the MySolutions Personalized Ecosystem

Retrieved on:

Lunedì, Dicembre 20, 2021

Medacta Launches 360 (Anterior and Posterior) Cervical Platform, Highlighting MySpine Cervical, a Further Enhancement to the MySolutions Personalized Ecosystem

Key Points:

Medacta Launches 360 (Anterior and Posterior) Cervical Platform, Highlighting MySpine Cervical, a Further Enhancement to the MySolutions Personalized Ecosystem
Medacta Launches 360(Anterior and Posterior) Cervical Platform, Highlighting MySpine Cervical, a Further Enhancement to the MySolutions Personalized Ecosystem
CASTEL SAN PIETRO, Switzerland, December 14, 2021 - Medacta is further demonstrating its commitment to innovation and personalized solutions by offering an end-to-end 360 cervical platform featuring ease-of-use, improved flexibility, stability[1] and accuracy[1] for posterior fixation and anterior cervical discectomy and fusion (ACDF).
"With the new 360 cervical platform, Medacta supports surgeons to treat the cervical spine both from the anterior and posterior approaches," says Francesco Siccardi, Chief Executive Officer of Medacta.
"The Medacta cervical platform features a range of high-level technologies that work together to provide versatility to surgeons and safety to patients.
This is a clear step forward towards our goal of developing highly personalized surgical solutions," concludes Siccardi.

Proactive news headlines including Auroch Minerals, DomaCom Australia, Kinetiko Energy and King River Resources

Retrieved on:

Mercoledì, Settembre 8, 2021

Click here

Key Points:

Click here
Kinetiko Energy Ltd (ASX:KKO) is in the process of negotiations with drilling contractors to undertake the upcoming 3-well drilling program at its flagship Amersfoort Project in South Africa.
Click here
Buru Energy Ltd (ASX:BRU) continues drilling the Rafael 1 well in Western Australias Canning Basin with operations on schedule and with no incidents or rig downtime.
Our written and video content is published on Proactive sites that collectively attract up to 10 million views per month.
For more information on how Proactive can help you make a difference, email us at [email protected]